PER 1.23% 8.0¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-81

  1. 373 Posts.
    lightbulb Created with Sketch. 20
    All sounds good uboy
    But were are the funds going to come from to push this thing forward through to approval in a few years
    Remember we have been down this path before firstly with Atl1102 in regards to our MS program,which stalled at phase 2 and never recovered, then Atl1103 in Agromegaly phase 2
    We seem to get the science right but just havent got the funds to get it all the way to market
    Seems like the market isnt convinced YET by looking at the price action lately
    I hope this times different and our fortunes change
    Thanks to all contributors on this forum especially sammy ur research and insights are invaluable thanks
    Good luck to all holders
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.